Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nippon Shinyaku Co., Ltd. ( (JP:4516) ) has issued an announcement.
Nippon Shinyaku has announced a slate of executive personnel changes, resolved by its board and to be finalized at the June 2026 shareholders’ meeting, including the appointment of sales and marketing planning chief Mitsuharu Koizumi as a new director and the promotion of Takanori Edamitsu to managing director overseeing business management and sustainability. The board reshuffle, which also sees the retirement of director Takashi Takaya and the reassignment of personnel, risk management and compliance oversight to Koizumi, signals a tightening of governance and continuity in leadership as the company balances its pharmaceutical and functional food operations with growing emphasis on sustainability and corporate oversight.
The most recent analyst rating on (JP:4516) stock is a Buy with a Yen5634.00 price target. To see the full list of analyst forecasts on Nippon Shinyaku Co., Ltd. stock, see the JP:4516 Stock Forecast page.
More about Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto and listed on the Tokyo Stock Exchange Prime Market. The company develops and markets ethical drugs and functional foods, focusing on both prescription pharmaceuticals and health-related products for domestic and global markets.
Average Trading Volume: 659,286
Technical Sentiment Signal: Buy
Current Market Cap: Yen339.6B
For an in-depth examination of 4516 stock, go to TipRanks’ Overview page.